# Influenza Vaccine and Pneumococcal Vaccine

> **NCT02582047** · PHASE4 · COMPLETED · sponsor: **Korea University Guro Hospital** · enrollment: 224 (actual)

## Conditions studied

- Influenza, Human
- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** Influenza vaccination with PPV23
- **BIOLOGICAL:** Influenza vaccination with PCV13

## Key facts

- **NCT ID:** NCT02582047
- **Lead sponsor:** Korea University Guro Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582047, "Influenza Vaccine and Pneumococcal Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02582047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*